Literature DB >> 9869589

Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

F Baquero1, J A García-Rodríguez, J G de Lomas, L Aguilar.   

Abstract

A nationwide susceptibility surveillance study of beta-hemolytic streptococcal isolates from pharyngeal swabs obtained in 11 Spanish hospitals between May 1996 and April 1997 against 12 antibiotics was carried out. Of the isolates 86% (786 of 914 isolates) were group A and 8.4% (77 of 914 isolates) were group C. No resistance was found to beta-lactam antibiotics, but significant differences (P < 0.001) with respect to lack of susceptibility to macrolides were found between groups (27% for group A and 12% for group C) and between seasons (13.2% in summer and 31.7% in winter). Most of these isolates displayed the M phenotype (low-level resistance to erythromycin and susceptibility to clindamycin).

Entities:  

Mesh:

Year:  1999        PMID: 9869589      PMCID: PMC89044     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990).

Authors:  J Liñares; R Pallares; T Alonso; J L Perez; J Ayats; F Gudiol; P F Viladrich; R Martin
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

Review 2.  Antibiotic management of group A streptococcal pharyngotonsillitis.

Authors:  J W Bass
Journal:  Pediatr Infect Dis J       Date:  1991-10       Impact factor: 2.129

3.  Erythromycin-resistant Streptococcus pyogenes.

Authors:  G Phillips; D Parratt; G V Orange; I Harper; H McEwan; N Young
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

4.  Erythromycin resistance in streptococci.

Authors:  E Perez Trallero; J M Garcia Arenzana; M Urbieta Egaña
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

5.  Erythromycin-resistant beta-hemolytic streptococci group A in Göteborg, Sweden.

Authors:  G Zackrisson; L Lind; K Roos; P Larsson
Journal:  Scand J Infect Dis       Date:  1988

6.  Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.

Authors:  C Betriu; A Sanchez; M Gomez; A Cruceyra; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

7.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

8.  [Antibiotic resistance to erythromycin, clindamycin and tetracycline of 573 strains of Streptococcus pyogenes (1992-1994)].

Authors:  B Orden; R Martínez; A López de los Mozos; A Franco
Journal:  Enferm Infecc Microbiol Clin       Date:  1996-02       Impact factor: 1.731

Review 9.  Antibiotic resistance in group A streptococci.

Authors:  M A Gerber
Journal:  Pediatr Clin North Am       Date:  1995-06       Impact factor: 3.278

10.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.

Authors:  S Maruyama; H Yoshioka; K Fujita; M Takimoto; Y Satake
Journal:  Am J Dis Child       Date:  1979-11
View more
  14 in total

1.  Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.

Authors:  E L Palavecino; I Riedel; X Berrios; S Bajaksouzian; D Johnson; E Kaplan; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).

Authors:  Emilio Pérez-Trallero; Jose E Martín-Herrero; Ana Mazón; Celia García-Delafuente; Purificación Robles; Victor Iriarte; Rafael Dal-Ré; Juan García-de-Lomas
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

3.  Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.

Authors:  C Betriu; M Redondo; M L Palau; A Sánchez; M Gómez; E Culebras; A Boloix; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 4.  Cefuroxime axetil: an updated review of its use in the management of bacterial infections.

Authors:  L J Scott; D Ormrod; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.

Authors:  E Bingen; F Fitoussi; C Doit; R Cohen; A Tanna; R George; C Loukil; N Brahimi; I Le Thomas; D Deforche
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  R Gómez-Lus; J J Granizo; L Aguilar; E Bouza; A Gutierrez; J García-de-Lomas
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility.

Authors:  Sebastián Albertí; César García-Rey; María A Domínguez; Lorenzo Aguilar; Emilia Cercenado; Miguel Gobernado; Adela García-Perea
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 8.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 9.  Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.

Authors:  Markus Zeitlinger; Claudia Christina Wagner; Birgit Heinisch
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 10.  Addressing the burden of group A streptococcal disease in India.

Authors:  Anita Shet; Edward Kaplan
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.